Program Schedule

135
Viral Infections: Treatment and Prevention

Friday, October 10, 2014: 12:30 PM-2:00 PM
Room: The Pennsylvania Convention Center: IDExpo Hall BC

Tracks: Adult ID, Epidemiology and Infection Control, Global ID, HIV-STD-TB, Investigative ID, Pediatric ID

Presentations:
BanLec, a banana lectin, is a potent inhibitor of Middle East respiratory syndrome coronavirus in in vitro assays
Jasper Chan, MBBS, FRCPath ; Kwok-Hung Chan, PhD, FRCPath ; Dan Boudreaux, PhD ; Michael Swanson, PhD ; David Markovitz, MD ; Kwok-Yung Yuen, MD
Posters
  • Poster_2014_09_30.pdf (541.0 kB)
  • Compliance of rabies post exposure prophylaxis and rabies vaccine application problems
    Asim Ulcay ; Mustafa Hatipoglu ; Oral Oncul ; Deniz Eray Gokce ; Vedat Turhan ; Hakan Erdem ; Levent Gorenek
    Self-administration of intranasal influenza vaccine: immunogenicity and volunteer acceptance
    Timothy Burgess, MD, MPH ; Clinton K. Murray, MD ; Mary Bavaro, MD ; Michael Landrum, MD ; Nicholas Martin, PhD ; Daniel Ewing, BS ; Kanakatte Raviprakash, PhD ; Jessica Rosas, BS ; Elizabeth Zell, MStat ; Kenneth Wilkins, PhD ; Deepika Mor, MS ; Eugene Millar, PhD
    Effectiveness of Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccines in Active Duty Members of the US Military
    Herve Caspard, MD ; Amy Steffey, DVM, MPH ; Nicholas M. Sicignano, MPH ; Christopher S. Ambrose, MD
    Posters
  • FLU14015.3165.pdf (209.3 kB)
  • Efficacy of Live Attenuated Influenza Vaccine Upon Revaccination of Children
    Herve Caspard, MD ; Christopher S. Ambrose, MD ; Terho Heikkinen, MD, PhD ; Robert B . Belshe, MD
    Posters
  • FLU14015.3166.pdf (183.2 kB)
  • Evaluation of Drug-Drug Interaction between Daclatasvir and Methadone or Buprenorphine/Naloxone
    Tushar Garimella, PhD ; Reena Wang, MD ; Wen-Lin Luo, PhD, MSc ; Philip Wastall, BSc ; Hamza Kandoussi, MSc ; Michael Demicco, MD ; Robert Bruce, MD, MA, MSc ; Carey Hwang, MD, PhD ; Richard Bertz, PhD ; Marc Bifano, MS
    Clinical Presentation and Risk Factors for Cytomegalovirus Colitis in Adult Immunocompetent Patients
    Jae-Hoon Ko, MD ; Kyong Ran Peck, MD ; Ji-Yong Lee, MD ; Woojoo Lee, MD ; Sun Young Cho, MD ; Eun-Jeong Joo, MD ; Young Eun Ha, MD ; Cheol-in Kang, MD ; Doo Ryeon Chung, MD ; Nam Yong Lee, MD, PhD ; Jae-Hoon Song, MD
    Use of First Positive Cytomegalovirus (CMV) PCR Determination to Differentiate a Viral Blip From Established CMV Infection in Transplant Recipients
    Isabelle Lodding, Pre-Graduate Research Fellow ; Caspar Da Cunha-Bang, MD PhD ; Finn Gustafsson, MD, Phd ; Martin Iversen, MD, D.M.Sc. ; Nikolai Kirkby, MSc Phd ; Allan Rasmussen, MD ; Søren Schwartz Sørensen, MD, D.M.Sc. ; Henrik Sengeloev, MD, D.M.Sc. ; Lars Vindeloev, MD, D.M.Sc. ; Jens Lundgren, MD, D.M.Sc., Professor
    Peramivir Safety in Hospitalized Influenza
    Sylvia Dobo, MD ; Jenna Elder, PhD ; Phil Collis, PhD ; William Sheridan, MB BS
    Posters
  • 1169_IDWPOSTER.pdf (187.9 kB)
  • OUTCOMES OF PERAMIVIR FOR AVIAN INFLUENZA VIRUS(H7N9):A SINGLE-CENTER EXPERIENCE
    Ting Zhang ; Xiuhong Xi ; Tao Li ; Kai Lin ; Hongzhou Lu ; Shuihua Lu
    The development of influenza virus variants with reduced susceptibility following peramivir treatment: an analysis of clinical and post-marketing experience
    Phil Collis, PhD ; Paul Zoeteweij, PhD ; Hans Bunschoten, PhD ; Ray Taylor, MBA ; YS Babu, PhD ; William Sheridan, MB BS
    Long-term Immunogenicity and Safety of an Investigational Herpes Zoster Subunit Vaccine in Older Adults
    Himal Lal, MD ; Roman Chlibek, MD, PhD ; Lars Rombo, MD, PhD ; Karlis Pauksens, MD ; Tino F. Schwarz, PhD ; Georg Plassmann, MD, PhD ; Jan H. Richardus, MD, PhD ; Gini G.C. Van Rijckevorsel, MD, MSc, PhD ; Grégory Catteau, MSc ; Thomas Heineman, MD, PhD
    In Vitro Antiviral and Synergistic Effects of Thiazolides and Oseltamivir Carboxylate Against Human Influenza A and B Viruses
    Gabriele Landolt, DVM, PhD ; Lori Bentsen, BS ; Debbie Bush, DVM, MS ; Cindy Hong, BS
    Relapse in patients with chronic hepatitis B infection treated with oral antivirals (nucleotide / nucleoside), after treatment discontinuation
    Mucahit Yemisen ; Sibel Yildiz Kaya ; Ilker Balkan ; Bilgul Mete ; Resat Ozaras ; Nese Saltoglu ; Recep Ozturk ; Fehmi Tabak
    Posters
  • TabakF.pdf (1.6 MB)
  • Comparison of the Accelerated and Standard Vaccination Schedules Against Hepatitis B in Healthy Adults
    Makram Koubaa, MD ; Chakib Marrakchi, MD ; Boussaima Hammami, MD ; Kaoula Rekik, MD ; Najoua Kteta, MD ; Imed Maaloul, MD ; Lamia Berrajah, MD ; Mounir Ben Jemaa, MD
    Implementing Hepatitis C Treatment Programs in Comprehensive HIV Clinics: The Health Resources and Services Administration (HRSA) Special Projects of National Significance (SPNS) Hepatitis C Treatment Expansion Initative
    Todd Wills, MD ; Martha Friedrich, PhD ; Jeffrey Beal, MD ; Charurut Somboonwit, MD ; Sean Mcintosh ; Anthony Bork ; Melinda Tinsley, MA ; Adan Cajina, MS ; Pamela Belton ; Jessica Xavier, MPH ; Rupali Doshi, MD, MS ; Renetta Boyd ; Natalie Solomon, MPH
    Posters
  • Wills HRSA HCV POSTER-2.pdf (323.3 kB)
  • CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, idweek.org. All Rights Reserved.

    Follow IDWeek